Publications and communications of Brigitte Evrard

Degey, M., Berger, M., Evrard, B., & Piel, G. (31 January 2024). New amphiphilic polymers with variable length and number of lipid chains as alternatives to PEG for the formulation of lipid nanoparticles encapsulating siRNA [Poster presentation]. CIRM DAY - Scientific day, Liege, Belgium.

Gauthy, C., Gihozo Uwera, A., Evrard, B., Malgrange, B., & Piel, G. (31 January 2024). Optimization of liposomal composition to efficiently encapsulate dexamethasone or dexamethasone phosphate and enable their sustained release [Poster presentation]. CIRM Day, Liège, Belgium.

Koch, N., Jennotte, O., Lechanteur, A., DEVILLE, M., Charlier, C., Cardot Jean-Michel, CHIAP, P., & Evrard, B. (2024). An Intravenous Pharmacokinetic Study of Cannabidiol Solutions in Piglets through the Application of a Validated Ultra-High-Pressure Liquid Chromatography Coupled to Tandem Mass Spectrometry Method for the Simultaneous Quantification of CBD and Its Carboxylated Metabolite in Plasma. Pharmaceutics. doi:10.3390/pharmaceutics16010140

Gaspar, A., Philippe, G., Evrard, B., Herné, P., Manfredini, T., & Delguste, C. (21 December 2023). VET&PHARM pilot project: A case study focusing on the perceived value of a pilot seminar on interprofessional communication for students in Pharmacy and Veterinary Medicine in the rational delivery of drugs for veterinary use [Poster presentation]. 10th FarahDay of the Faculuty of Veterinary Medicine, Liège, Belgium.

Jennotte, O., Koch, N., Lechanteur, A., & Evrard, B. (September 2023). Formulation and quality consideration of cannabidiol printed forms produced by fused-deposition modeling. Journal of Drug Delivery Science and Technology, 87, 104837. doi:10.1016/j.jddst.2023.104837

Penoy, N., Delma, K. L., Grignard, B., Evrard, B., & Piel, G. (23 May 2023). The use of supercritical CO2 to develop liposomes encapsulating active pharmaceutical ingredients for pulmonary administration [Poster presentation]. 19th European Meeting on Supercritical Fluids, Budapest, Hungary.

Gauthy, C., Penoy, N., Evrard, B., Malgrange, B., & Piel, G. (28 April 2023). Development of optimized liposomes for sustained-release transtympanic administration [Paper presentation]. 21st Forum of Pharmaceutical Sciences, Blankenberge, Belgium.

Berger, M., Degey, M., Leblond Chain, J., Maquoi, E., Evrard, B., Lechanteur, A., & Piel, G. (10 February 2023). Effect of PEG Anchor and Serum on Lipid Nanoparticles: Development of a Nanoparticles Tracking Method. Pharmaceutics, 15 (2). doi:10.3390/pharmaceutics15020597

Gauthy, C., Penoy, N., Evrard, B., Malgrange, B., & Piel, G. (01 February 2023). Development of a sustained-release form of dexamethasone for the local treatment of sensorineural hearing loss [Poster presentation]. CIRM Day, Liège, Belgium.

Delma, K. L., Penoy, N., Sakira, A. K., EGREK, S., Sacheli, R., Grignard, B., Hayette, M.-P., Issa Somé, T., Evrard, B., Semdé, R., & Piel, G. (11 January 2023). Use of supercritical CO2 for the sterilization of liposomes: Study of the influence of sterilization conditions on the chemical and physical stability of phospholipids and liposomes. European Journal of Pharmaceutics and Biopharmaceutics, 183, 112 - 118. doi:10.1016/j.ejpb.2023.01.002

Nyamba, I., Sombié, C., Lechanteur, A., Semdé, R., & Evrard, B. (02 February 2022). Complexation with cyclodextrins and solid dispersions formation as physical formulation approaches for improving aqueous solubility and bioavailability of ellagic acid [Paper presentation]. CIRM Day 2022, Liège, Belgium.

Dori, D., Ouedraogo, H. W. B., Houngue, P. D., Gbaguidi, F. A., Evrard, B., Quetin-Leclercq, J., & Semdé, R. (October 2021). Study of Manufacturing Conditions of Medicines Derived from Traditional Pharmacopoeia in Benin and Burkina Faso. Phytothérapie, 19 (5-6), 372-378. doi:10.3166/phyto-2021-0295

Penoy, N., Grignard, B., Evrard, B., & Piel, G. (06 April 2021). Double Encapsulation in liposomes for pulmonary administration produced by an innovative supercritical process [Paper presentation]. Controlled Release Society BeNeLux&France Early Career Scientists Meeting (online).

Penoy, N., Koch, N., Grignard, B., Evrard, B., & Piel, G. (March 2021). The quality by design strategy to prepare different liposomes formulations by a new supercritical fluid method [Poster presentation]. APGI Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology.

Lechanteur, A., & Evrard, B. (2020). Influence of Composition and Spray-Drying Process Parameters on Carrier-Free DPI Properties and Behaviors in the Lung: A review. Pharmaceutics. doi:10.3390/pharmaceutics12010055

Bayiha, J. C., Evrard, B., Cataldo, D., De Tullio, P., & Mingeot-Leclercq, M.-P. (2020). The Budesonide-Hydroxypropyl-β-Cyclodextrin Complex Attenuates ROS Generation, IL-8 Release and Cell Death Induced by Oxidant and Inflammatory Stress. Study on A549 and A-THP-1 Cells. Molecules, 25, 4882. doi:10.3390/molecules25214882

Penoy, N., Avohou, T. H., Lebrun, P., Evrard, B., & Piel, G. (11 December 2019). A quality by design approach for liposomes production by innovative method using supercritical fluids: which parameters use to obtain good physicochemical characteristics? [Paper presentation]. Second CIRM Scientific Day, Liège, Belgium.

Sounouvou, A. G. H. T., Toukourou, H., Lechanteur, A., Piel, G., Quetin-Leclercq, J., Gbaguidi, F., & Evrard, B. (11 December 2019). Development of dermatological dosage forms based on essential oils for the treatment of common skin infections [Paper presentation]. 2nd CIRM day, Liege, Belgium.

Lechanteur, A., Sanna, V., Duchemin, A., Evrard, B., Mottet, D., & Piel, G. (August 2018). Cationic Liposomes Carrying siRNA: Impact of Lipid Composition on Physicochemical Properties, Cytotoxicity and Endosomal Escape [Paper presentation]. 12th International Conference and Workshop on Biological barriers, Saarbruck, Germany.

Lechanteur, A., Furst, T., Delvenne, P., Evrard, B., Hubert, P., & Piel, G. (07 December 2017). Promoting vaginal distribution of two active siRNA-complexed in liposomes for cervical cancer treatment [Paper presentation]. SF Nano Annual Meeting 2017, Bordeaux, France.

Lechanteur, A., Furst, T., Delvenne, P., Evrard, B., Hubert, P., & Piel, G. (05 December 2017). Promoting vaginal distribution of two active siRNA-complexed in liposomes for cervical cancer treatment [Paper presentation]. 4th SF Nano Annual Meeting, Bordeaux, France.

Bigazzi, W., Dufour, G., De Tullio, P., Piel, G., Cataldo, D., & Evrard, B. (June 2017). Interest of cylodextrins in spray-dried microparticles formulation for sustained pulmonary delivery of budesonide [Poster presentation]. EuroDrying’2017 – 6th European Drying Conference, Liège, Belgium.

Lechanteur, A., Furst Tania, Evrard, B., Delvenne, P., Hubert, P., & Piel, G. (25 April 2017). Promoting vaginal distribution of two active siRNA-complexed in liposomes for cervical cancer treatment [Paper presentation]. 1st SPLC-Controlled Release Society, Santiago de Compostela, Spain.

dos Santos, A., Bayiha, J., Dufour, G., Cataldo, D., Evrard, B., Silva, L. C., Deleu, M., & Mingeot-Leclercq, M.-P. (2017). Changes in biophysical membrane properties induced by the Budesonide/ Hydroxy-β-cyclodextrin complex. Biochimica et Biophysica Acta. Biomembranes. doi:10.1016/j.bbamem.2017.06.010

Pestieau, A., Lebrun, S., Cahay, B., & Evrard, B. (28 October 2015). In vitro and in vivo evaluation of an optimized fenofibrate lipid based solid dispersion produced by a PGSS process [Poster presentation]. 2015 AAPS Annual Meeting and Exposition, Orlando, United States.

Pestieau, A., Lebrun, S., Cahay, B., & Evrard, B. (28 October 2015). In vitro and in vivo evaluation of an optimized fenofibrate lipid based solid dispersion produced by a PGSS process [Paper presentation]. 2015 AAPS Annual Meeting and Exposition, Orlando, United States.

Dufour, G., Evrard, B., & De Tullio, P. (2015). Rapid quantification of 2-hydroxypropyl-β-cyclodextrin in liquid pharmaceutical formulations by 1H nuclear magnetic resonance spectroscopy. European Journal of Pharmaceutical Sciences. doi:10.1016/j.ejps.2015.03.005

Lechanteur, A., Furst, T., Delvenne, P., Evrard, B., Hubert, P., & Piel, G. (2015). Anti-E6/E7/MCL-1 pegylated lipoplexes for a vaginal treatment of cervical cancer [Paper presentation]. 1st European Conference on Pharmaceutics: Drug Delivery, Reims, France.

Furst, T., Lechanteur, A., Hubert, P., Evrard, B., & Piel, G. (03 November 2014). DEVELOPMENT AND CHARACTERIZATION OF PEGYLATED LIPOPLEXES TO BE ENTRAPPED IN HEC SPONGES FOR VAGINAL DELIVERY [Poster presentation]. 2014 AAPS Annual Meeting and Exposition, San Diego, United States.

Pestieau, A., & Evrard, B. (November 2014). Development of a biphasic in vitro dissolution test for the study of a BCS II API lipid based oral dosage form produced by a PGSS process [Poster presentation]. 2014 AAPS Annual Meeting and Exposition, San Diego, United States.

Furst, T., Lechanteur, A., Hubert, P., Evrard, B., & Piel, G. (20 October 2014). DEVELOPMENT AND CHARACTERIZATION OF PEGYLATED LIPOPLEXES TO BE ENTRAPPED IN HEC SPONGES FOR VAGINAL DELIVERY [Poster presentation]. 3rd NanoFar Autumn School, Louvain, Belgium.

Lechanteur, A., Furst, T., Kanber, E., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (04 October 2014). Development and optimization of pegylated lipoplexes for vaginal application [Paper presentation]. SFNano Workshop 2014, Porto, Portugal.

Frère, A., Tempelaar, S., Peixoto, P., Peulen, O., Evrard, B., Dubois, P., Mespouille, L., Mottet, D., & Piel, G. (28 August 2014). Polyplex based on polycarbonate polymesr for an efficient delivery of an anti-angiogenic siRNA [Paper presentation]. Translational Nanomedicine, Angers, France.

Furst, T., Lechanteur, A., Hubert, P., Evrard, B., & Piel, G. (27 August 2014). DEVELOPMENT OF PEG-COATED LIPOPLEXES TO BE INCORPORATED INTO MUCOADHESIVE HEC-SPONGES [Poster presentation]. Translational Nanomedicine, International Meeting, Angers, France.

Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (19 May 2014). ASSOCIATION OF LIPOSOMES AND siRNA FOR A LOCAL TREATMENT OF CERVICAL CANCER [Poster presentation]. GIGA-Cancer Day 2014.

Furst, T., Lechanteur, A., Hubert, P., Evrard, B., & Piel, G. (03 April 2014). DEVELOPMENT OF PEG-COATED LIPOPLEXES WITH siRNA ANTI E6/E7 ONCOPROTEINS FOR THE TREATMENT OF HPV CANCERS [Poster presentation]. 9th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Lisbonne, Portugal.

Furst, T., Lechanteur, A., Hubert, P., Evrard, B., & Piel, G. (16 February 2014). Development of PEG-coated lipoplexes with siRNA anti-E6/E7 oncoproteins to be incorporated into mucoadhesive HEC-sponges for the treatment of HPV cancers [Poster presentation]. 10th International Conference and Workshop on Biological Barriers, Saarbrucken, Germany.

Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (16 February 2014). Development of anti-HPV lipoplexes formulations for the treatment of cervical cancer [Poster presentation]. 10th International conference and workshop on Biological Barriers.

Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (27 January 2014). Development of anti-HPV lipoplexes formulations for the treatment of cervical cancer [Poster presentation]. GIGA-Day 2014.

Frère, A., Kawalec, M., Tempelaar, S., Peixoto, P., Peulen, O., Evrard, B., Dubois, P., Mespouille, L., Mottet, D., & Piel, G. (2014). Polyplex Based On Polycarbonate Polymers For An Efficient Delivery Of An Anti-Angiogenic siRNA [Poster presentation]. 3rd NanoFar Autumn School, Brussels, Belgium.

Frère, A., Krier, F., Evrard, B., Mottet, D., & Piel, G. (2014). Polyplex Based On Polycarbonate Polymers For An Efficient Delivery Of An Anti-Angiogenic siRNA [Poster presentation]. 2014 AAPS Annual Meeting and Exposition, San Diego, United States.

Mehuys, E., Paemeleire, K., Van Hees, T., Christiaens, T., Van Bortel, L., Van Tongelen, I., Philippe, G., Prévôt, M.-L., Evrard, B., Piette, M., De Bolle, L., Remon, J., & Boussery, K. (2014). Zelfbehandeling van frequente hoofdpijn : een Belgische apotheekstudie [Paper presentation]. Prisma Symposium, Amersfoort, Netherlands.

Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., RONCARATI, P., Piel, G., & Hubert, P. (05 December 2013). Development of anti-HPV lipoplexes formulations for the treatment of cervical cancer [Poster presentation]. Séminaire des chercheurs du Télévie 2014.

Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (03 December 2013). Development of anti-HPV lipoplexes for the treatment of cervical cancer [Paper presentation]. 28ième Journées Scientifiques du GTRV, Angers, France.

Furst, T., Lechanteur, A., Hubert, P., Evrard, B., & Piel, G. (02 December 2013). Development of peggylated lipoplexes with siRNA anti-E6/E7 oncoproteins for the treatment og cancers induced by HPV [Poster presentation]. GTRV, Orléans, France.

Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., & Hubert, P. (17 October 2013). Development of anti-HPV lipoplexes for the treatment of cervical cancer [Paper presentation]. Dix-septième forum des sciences pharmaceutiques.

Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., RONCARATI, P., Piel, G., & Hubert, P. (2013). Development of anti-HPV lipoplexes for the treatment of cervical cancer [Poster presentation]. Cancer GIGA-Day 2013, liège, Belgium.

Lechanteur, A., Evrard, B., Delvenne, P., RONCARATI, P., Hubert, P., & Piel, G. (November 2012). Development and optimization of lipoplex vectors for an antisens therapeutic approach in the context of HPV induced lesions [Poster presentation]. Ecole doctorale en cancérologie expérimentale, liège, Belgium.

Frère, A., Kawalec, M., Collard, L., Matheus, N., Peixoto, P., Evrard, B., Dubois, P., Mespouille, L., Mottet, D., & Piel, G. (22 October 2012). Characterization and transfection experiments of polyplexes targeting HDAC7 [Poster presentation]. NanoFar Autumn School, Angers, France.

Furst, T., Lechanteur, A., Evrard, B., Delvenne, P., Hubert, P., Piette, M., & Piel, G. (22 October 2012). Development of a topical formulation containing lipoplexes able to inhibit E6 and E7 genes for the treatment of cervix cancer caused by HPV16 and HPV18 [Poster presentation]. NanoFar 1st Autumn School, Angers, France.

Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Hubert, P., & Piel, G. (22 October 2012). Development of a topical formulation containing lipoplexes able to inhibit E6 and E7 genes for the treatment of cervix cancer caused by HPV16 and HPV18 [Poster presentation]. NanoFar Automn School, Angers, France.

Krier, F., mantanus, J., Ziemons, E., Hubert, P., & Evrard, B. (16 October 2012). Comparison of in-line active content determination of polymeric implant by near infrared spectroscopy and Raman spectroscopy [Poster presentation]. Congrés annuel de l'AAPS2012.

Mehuys, E., Paemeleire, K., Van Hees, T., Van Bortel, L., Van Tongelen, I., Philippe, G., Prévôt, M.-L., Evrard, B., Piette, M., De Bolle, L., Remon, J., & Boussery, K. (September 2012). Zelfbehandeling van frequente hoofdpijn : een Belgische apotheekstudie [Paper presentation]. Second Belgian Pharmaceutical Care Symposium : Quality of care - Care for quality, Bruxelles, Belgium.

Donnez, J., Van Langendonkt, A., Defrère, S., Foidart, J.-M., Jérôme, C., Evrard, B., Riva, R., Krier, F., & Mestdagt, M. (19 July 2012). Implant comprising a core and a tube encasing the core.

Donnez, J., Van Langendonkt, A., Defrère, S., Foidart, J.-M., Jérôme, C., Evrard, B., Riva, R., Krier, F., & Mestdagt, M. (18 July 2012). Implant comprising a core and a tube encasing the core.

Ziemons, E., Mantanus, J., Rozet, E., Lebrun, P., Klinkerberg, R., Streel, B., Evrard, B., & Hubert, P. (March 2012). AN INNOVATIVE APPROACH TO SELECT THE PREDICTION MODEL IN THE DEVELOPMENT OF NIR SPECTROSCOPIC METHODS [Poster presentation]. AGROSTAT 2012, Paris, France.

Mantanus, J., Rozet, E., Van Butsele, K., De Bleye, C., Ceccato, A., Evrard, B., Hubert, P., & Ziemons, E. (October 2011). Silicone-based drug reservoirs manufacturing process - Critical quality attributes evaluation using NIR and Raman spectroscopy [Poster presentation]. AAPS Annual Meeting and Exposition, Washington, United States.

De Bleye, C., Mantanus, J., Rozet, E., Van Butsele, K., Marini Djang'Eing'A, R., Ceccato, A., Evrard, B., Hubert, P., & Ziemons, E. (September 2011). BUILDING THE QUALITY INTO THE POLYMERIC SOLID DOSAGE FORM MANUFACTURING LINE - CRITICAL QUALITY ATTRIBUTES EVALUATION WITH NIR AND RAMAN PAT TOOLS [Poster presentation]. Recent Development in Pharmaceutical Analysis (RDPA), Pavia, Italy.

Berton, A., Piel, G., & Evrard, B. (2011). Powdered lipid nano and microparticles : production and applications. Recent Patents on Drug Delivery and Formulation, 5 (3), 188-200. doi:10.2174/187221111797200588

Ziemons, E., Mantanus, J., Rozet, E., Lebrun, P., Klinkenberg, R., Streel, B., Moonen, F., Evrard, B., & Hubert, P. (08 December 2010). Vibrational spectroscopy in pharmaceutical industry: From development of the most appropriate predictive model to routine implementation [Poster presentation]. BioWin Day 2010, Louvain-la-Neuve, Belgium.

Ziemons, E., Mantanus, J., Rozet, E., Lebrun, P., Klinkenberg, R., Streel, B., Evrard, B., Moonen, F., & Hubert, P. (02 December 2010). Use of tolerance intervals in the development of near infrared spectroscopic methods: An innovative way to select the most appropriate calibration model [Poster presentation]. Chimiométrie 2010, Paris, France.

Krier, F., Brion, M., Debrus, B., Lebrun, P., Driesen, A., Ziemons, E., Evrard, B., & Hubert, P. (15 November 2010). Optimisation and validation of a fast HPLC method for the quantification of sulindac and its related impurities [Poster presentation]. The FIP Pharmaceutical Sciences World Congress 2010 in association with the AAPS Annual Meeting & Exposition, new orléans, United States.

Mantanus, J., Ziemons, E., Streel, B., Klinkenberg, R., Evrard, B., Rantanen, J., & Hubert, P. (15 November 2010). NIR monitoring of solid and liquid forms manufacturing – Development and validation of in-line quantitative methods [Poster presentation]. FIP Pharmaceutical Sciences 2010 world congress, New Orleans, United States.

Mantanus, J., Lebrun, P., Rozet, E., Evrard, B., Hubert, P., & Ziemons, E. (14 October 2010). La spectroscopie proche infrarouge et Raman: Nouvelles armes vertes dans le contrôle de la qualité du médicament [Poster presentation]. Journée Scientifique Annuelle de la Société Royale de Chimie: Chimie Verte, Gembloux, Belgium.

Mantanus, J., Ziemons, E., Van Butsele, K., Evrard, B., Ceccato, A., & Hubert, P. (24 September 2010). NIR AND RAMAN SPECTROSCOPY AS PAT TOOLS FOR THE MANUFACTURING OF SILICONE-BASED DRUG RESERVOIRS [Paper presentation]. Drug Analysis 2010, Anvers, Belgium.

Ziemons, E., Mantanus, J., Rozet, E., Lebrun, P., Klinkenberg, R., Streel, B., Evrard, B., & Hubert, P. (September 2010). An innovative approach to select the prediction model in the development of NIR spectroscopy methods [Poster presentation]. Drug Analysis, Antwerpen, Belgium.

Mantanus, J., Ziemons, E., Evrard, B., Van Butsele, K., Ceccato, A., & Hubert, P. (05 May 2010). NIR Real-time monitoring of a silicone-based drug reservoir crosslinking process [Poster presentation]. 4th Pan European Pat Science conference, Kuopio, Finland.

Mantanus, J., Ziemons, E., Streel, B., Klinkenberg, R., Evrard, B., Rantanen, J., & Hubert, P. (05 May 2010). NIR as a PAT tool for solid and liquid forms manufacturing - Development and validation of in-line quantitative methods [Poster presentation]. 4th Pan European Pat Science conference, Kuopio, Finland.

Castagne, D., Dive, G., Evrard, B., Frederich, M., & Piel, G. (2010). Spectroscopic studies and molecular modeling for understanding the interactions between cholesterol and cyclodextrins. Journal of Pharmacy and Pharmaceutical Sciences, 13 (2), 362-377. doi:10.18433/j3bs34

Ouédraogo, M., Semdé, R., Somé, I. T., Ouédraogo, M., Ouédraogo, R., Henschel, V., Evrard, B., Dubois, J., Amighi, K., & Guissou, I. P. (December 2009). Development of an in vitro endotoxin test for monoolein-water liquid crystalline gel for use as an implant. Tropical Journal of Pharmaceutical Research, 8 (6), 501-508.

Mantanus, J., Ziemons, E., Streel, B., Klinkenberg, R., Evrard, B., Hubert, P., & Rantanen, J. (September 2009). Production line real time near infrared (NIR) monitoring [Paper presentation]. 3rd Annual Pharmaceutical Solid State Research Cluster Symposium, Copenhagen, Denmark.

Mantanus, J., Ziemons, E., Streel, B., Klinkenberg, R., Evrard, B., Hubert, P., & Rantanen, J. (August 2009). Quantitative in-line monitoring of pharmaceutical pellets active content using near infrared spectroscopy [Poster presentation]. 3rd Annual Pharmaceutical Solid State Research Cluster Symposium, Copenhagen, Denmark.

Mantanus, J., Ziemons, E., Streel, B., Klinkenberg, R., Evrard, B., Hubert, P., & Rantanen, J. (June 2009). Interfacing near infrared (NIR) spectroscopy with production line - Role of sample movement and density [Poster presentation]. Premier European Platform for Advancing Pharmaceutical Sciences, Nice, France.

Zalfen, A., Nizet, D., Jérôme, C., Jérôme, R., frankenne, F., Foidart, J.-M., Maquet, V., Lecomte, F., Hubert, P., & Evrard, B. (November 2008). Controlled release of drugs from multi-component biomaterials. Acta Biomaterialia, 4 (6), 1788-1796. doi:10.1016/j.actbio.2008.05.021

Guéders, M., Bertholet, P., Perin, F., Rocks, N., Marée, R., Botta, V., Louis, R., Foidart, J.-M., Noël, A., Evrard, B., & Cataldo, D. (2008). A novel formulation of inhaled doxycycline reduces allergen-induced inflammation, hyperresponsiveness and remodeling by matrix metalloproteinases and cytokines modulation in a mouse model of asthma. Biochemical Pharmacology, 75 (2), 514-26. doi:10.1016/j.bcp.2007.09.012

Mantanus, J., Ziemons, E., Lebrun, P., Rozet, E., Klinkenberg, R., Streel, B., Evrard, B., & Hubert, P. (2008). Determination of moisture content in pharmaceutical pellets using near infrared spectroscopy: Method development and validation [Paper presentation]. PAT Workshop, Gent, Belgium.

Volvert, M.-L., Seyen, S., Piette, M., Evrard, B., Gangolf, M., Plumier, J.-C., & Bettendorff, L. (2008). Benfotiamine, a synthetic S-acyl thiamine derivative, has different mechanisms of action and a different pharmacological profile than lipid-soluble thiamine disulfide derivatives. BMC Pharmacology, 8, 10. doi:10.1186/1471-2210-8-10

Piel, G., Ducat, E., Grammenos, A., Evrard, B., & Delattre, L. (October 2007). Encapsulation of betamethasone-HP-gCD complex in deformable liposomes [Poster presentation]. 1st conference on "innovation in drug delivery: from biomaterials to devices", Naples, Italy.

Evrard, B., Bertholet, P., Guéders, M., Piette, M., Piel, G., Cataldo, D., & Delattre, L. (2007). Contribution of cyclodextrins in the developement of different pharmaceutical formulations of a nex matrix metalloproteinase inhibitor. Journal of Inclusion Phenomena and Molecular Recognition in Chemistry, 57 (1-4), 303-308. doi:10.1007/s10847-006-9177-z

Hubert, P., Doyen, J., Chapelle, X., Evrard, B., Gerday, C., Boniver, J., Foidart, J.-M., & Jacobs, N. (2007). Phase I/IIclinical trial of local GM-CSF application in patients with cervical HPV-associated low grade squamous intraepithelial lesions [Paper presentation]. 24th International Papillomavirus Conference and Clinical Workshops, Bejing, China.

Piel, G., Coia, I., Uhoda, E., Pierard, G., Evrard, B., & Delattre, L. (October 2006). Assessment of betamethasone-in-cyclodextrin-in-liposome induced skin blanching response [Poster presentation]. Skin and Formulation, 2nd Symposium, Versailles, France.

Piette, M., Evrard, B., Frankenne, F., Chiap, P., Bertholet, P., Castagne, D., Foidart, J.-M., Delattre, L., & Piel, G. (June 2006). Pharmacokinetic study of a new synthetic MMP inhibitor (Ro 28-2653) after IV and oral administration of cyclodextrin solutions. European Journal of Pharmaceutical Sciences, 28 (3), 189-195. doi:10.1016/j.ejps.2006.01.011

Hubert, C., Rozet, E., Boulanger, B., Dewé, W., Breuer, A., Collard, L., Evrard, B., & Hubert, P. (May 2006). Validation of a LC method for the determination of levonorgestrel released from a polymeric matrix. A two days protocol [Poster presentation]. Drug Analysis 2006, Namur, Belgium.

Chiap, P., Piette, M., Evrard, B., Frankenne, F., Christiaens, B., Piel, G., Cataldo, D., Foidart, J.-M., Delattre, L., Crommen, J., & Hubert, P. (05 March 2005). Automated method for the determination of a new matrix metalloproteinase inhibitor in ovine plasma and serum by coupling of restricted access material for on-line sample clean-up to liquid chromatography. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 817 (1), 109-117. doi:10.1016/j.jchromb.2004.08.042

Evrard, B., Bertholet, P., Guéders, M., Flament, M. P., Piel, G., Delattre, L., Gayot, A., Leterme, P., Foidart, J.-M., & Cataldo, D. (2004). Cyclodextrins as a potential carrier in drug nebulization. Journal of Controlled Release, 96 (3), 403-410. doi:10.1016/j.jconrel.2004.02.010

Hubert, P., Evrard, B., Maillard, C., Franzen-Detrooz, E., Delattre, L., Foidart, J.-M., Noël, A., Boniver, J., & Delvenne, P. (2004). Delivery of granulocyte-macrophage colony-stimulating factor in bioadhesive hydrogel stimulates migration of dendritic cells in models human papillomavirus-associated (pre)neoplastic epithelial lesions. Antimicrobial Agents and Chemotherapy, 48 (11), 4342-4348. doi:10.1128/AAC.48.11.4342-4348.2004

Piel, G., Moutard, S., Uhoda, E., Pilard, F., Pierard, G., Perly, B., Delattre, L., & Evrard, B. (2004). Skin compatibility of cyclodextrins and their derivatives: a comparative assessment using a corneoxenometry bioassay. European Journal of Pharmaceutics and Biopharmaceutics, 57 (3), 479-82. doi:10.1016/j.ejpb.2003.12.004

Piel, G., Boulmedarat, L., Bochot, A., Evrard, B., Delattre, L., & Fattal, E. (12 November 2003). Influence de la methyl-b-cyclodextrine sur la cinetique de libération de l'inuline encapsulée dans des liposomes bioadhésifs [Poster presentation]. 18ème Journée Scientifique du GTRV, Lille, France.

Piel, G., Evrard, B., Van Hees, T., Pierard, G., de LA BRASSINNE, M., & Delattre, L. (April 2000). Development of a cutaneous hydrogel containing miconazole hydroxypropyl-b-cyclodextrin and lactic acid: study of its tolerability and efficacy [Paper presentation]. IXth Forum of Pharmaceutical Sciences, Blankenberge, Belgium.

Piel, G., Hayette, M.-P., Evrard, B., Van Hees, T., De Mol, P., & Delattre, L. (May 1999). A comparative study of the antimycotic activity of a miconazole-HP-b-CD solution to a surfactant solution [Paper presentation]. VIIIth Forum of Pharmaceutical Sciences, Spa, Belgium.